We are live on ! Find out more
REVBU

Revelation Biosciences, Inc. Unit
REVBU

Delisted

REVBU was delisted on the 11th of January, 2023.

Back to rankings

11 hedge funds and large institutions have $22.6M invested in Revelation Biosciences, Inc. Unit in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+11
Holders Change %
–
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
+$10.5M
2
PAMP
Polar Asset Management Partners
Ontario, Canada
+$3.55M
3
CH
CVI Holdings
Delaware
+$3.05M
4
SCM
Shaolin Capital Management
Florida
+$2.38M
5
Walleye Capital
Walleye Capital
New York
+$738K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GCL
1
Glazer Capital LLC
New York
$11.2M +$10.5M +1,035,652 New
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$3.78M +$3.55M +350,000 New
CH
3
CVI Holdings
Delaware
$3.24M +$3.05M +300,000 New
SCM
4
Shaolin Capital Management
Florida
$2.53M +$2.38M +234,158 New
Jane Street
5
Jane Street
New York
$540K +$508K +50,000 New
Walleye Trading
6
Walleye Trading
New York
$523K +$492K +48,440 New
KIM
7
Karpus Investment Management
New York
$294K +$276K +27,200 New
EAM
8
Exos Asset Management
New York
$271K +$255K +25,117 New
UBS Group
9
UBS Group
Switzerland
$102K +$95.8K +9,441 New
PAM
10
Panagora Asset Management
Massachusetts
$86K +$80.5K +7,931 New
Walleye Capital
11
Walleye Capital
New York
$785 +$738K +72,660 New

REVBU Hedge Fund Activity: Q4 2020 in Review

11 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences, Inc. Unit (REVBU) for Q4 2020, worth a combined $22.6M.

Buyers outnumbered sellers: 11 funds opened new REVBU positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $10.5M.

  • 11 institutional investors held Revelation Biosciences, Inc. Unit (REVBU) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $22.6M of Revelation Biosciences, Inc. Unit stock for Q4 2020.
  • 11 funds opened new Revelation Biosciences, Inc. Unit positions in Q4 2020 and 0 closed out, a net change of +11 holders.
  • The largest Revelation Biosciences, Inc. Unit buyer in Q4 2020 was Glazer Capital LLC, an estimated $10.5M added.

Based on aggregated 13F filings for Q4 2020.